AEBP1 gene variants in infants with gastroschisis

Marcia L Feldkamp1, Neil E Bowles, Lorenzo D Botto

  • 1Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA. marcia.feldkamp@hsc.utah.edu

Insights

Researchers investigated the AEBP1 gene in gastroschisis cases, finding numerous variants but no significant differences compared to controls. These AEBP1 gene alterations were predicted to be benign, suggesting other factors may cause this abdominal wall defect.

Area of Science:

  • Genetics and Molecular Biology
  • Developmental Biology
  • Medical Genetics

Background:

  • Gastroschisis is a severe congenital abdominal wall defect.
  • The AEBP1 gene has two isoforms with distinct cellular roles.
  • Aclp, an AEBP1 isoform, is crucial for abdominal wall development in mice.

Purpose of the Study:

  • To investigate the role of the AEBP1 gene in the etiology of human gastroschisis.
  • To screen for novel variants in AEBP1 in gastroschisis patients.

Main Methods:

  • Sequencing of the AEBP1 gene in 40 gastroschisis cases.
  • Comparison of variant frequencies with a control population.
  • In silico prediction of variant pathogenicity.

Main Results:

  • Multiple novel variants in AEBP1 were identified in gastroschisis cases.
  • No significant difference in variant frequency was observed between cases and controls.
  • Predicted benign nature of identified AEBP1 variants.

Conclusions:

  • The AEBP1 gene variants found are unlikely to be the primary cause of gastroschisis.
  • Further research is needed to understand AEBP1's interaction with immune response pathways.
  • The etiology of gastroschisis, particularly its higher incidence in young women, remains largely unknown.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...